Simon Neuwahl

Simon Neuwahl is an experienced project manager and health economist at RTI, leading economic analysis tasks and moderating productive meetings. He is an expert in developing new cost-effectiveness models and adapting existing models to updated medical evidence. Mr. Neuwahl has over ten years of experience conducting economic analyses of diabetes and interventions to prevent diabetes. He also collects and analyzes cost data from clinical trials in a wide range of settings such as maternal health in developing countries and treatments for incontinence care in the U.S. Mr. Neuwahl is an advanced user of STATA and TreeAge to conduct cost-effectiveness analyses.

Currently, Mr. Neuwahl serves as a health economist and project director for the CDC Microsimulation of Nutrition, Diabetes, and Cardiovascular Disease (MONDAC) project and the follow-on project focused on the impacts of physical activity on diabetes and cardiovascular disease. He leads the literature review, work plan, expert panel meetings, and all report writing tasks. Additionally, he coordinates model deployment with CDC IT to conduct and respond to security compliance scans and 508 compliance scans. He is working to implement and validate the model, and publish a methods paper on how the model translates change in nutrition or physical activity into changes in health and related costs.